Investigation of urinary metabolomics in a phase I hookworm vaccine trial in Gabon.

Betouke Ongwe, Madeleine Eunice; Mouwenda, Yoanne D; Stam, Koen A; Kremsner, Peter G; Lell, Bertrand; Diemert, David; Bethony, Jeff; Bottazzi, Maria E et al. · PLoS One · 2022

rct · Level II

Where this comes from

Abstract

Metabolomics provides a powerful tool to study physiological changes in response to various perturbations such as vaccination. We explored whether metabolomic changes could be seen after vaccination in a phase I trial where Gabonese adults living either in rural or semi-urban areas received the subunit hookworm vaccine candidates (Na-GST-1 and Na-APR-1 (M74) adjuvanted with Alhydrogel plus GLA-AF (n = 24) or the hepatitis B vaccine (n = 8) as control. Urine samples were collected and assayed using targeted 1H NMR spectroscopy. At baseline, a set of metabolites significantly distinguished rural from semi-urban individuals. The pre- and post-vaccination comparisons indicated significant changes in few metabolites but only one day after the first vaccination. There was no relationship with immunogenicity. In conclusion, in a small phase 1 trial, urinary metabolomics could distinguish volunteers with different environmental exposures and reflected the safety of the vaccines but did not show a relationship to immunogenicity.

Medical subject headings